http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#Head http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg http://www.nanopub.org/nschema#hasAssertion http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#assertion http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg http://www.nanopub.org/nschema#hasProvenance http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#provenance http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg http://www.nanopub.org/nschema#hasPublicationInfo http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#pubinfo http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#assertion http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_1 http://purl.obolibrary.org/obo/RO_0002204 http://www.informatics.jax.org/marker/MGI:95758 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_1 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.obolibrary.org/obo/CL_0000136 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://purl.obolibrary.org/obo/UBERON_0002385 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_2 http://purl.obolibrary.org/obo/BFO_0000066 http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.bioontology.org/ontology/MSH/D007333 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate http://www.selventa.com/vocabulary/decreases http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#subject http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_1 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_2 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#assertion http://www.w3.org/2000/01/rdf-schema#label p(MGI:Slc2a4) -| bp(MESHPP:"Insulin Resistance") http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#provenance http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/description Approximately 61,000 statements. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/rights Copyright (c) 2011-2012, Selventa. All rights reserved. http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/dc/elements/1.1/title BEL Framework Large Corpus Document http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/authoredBy http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_4 http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://purl.org/pav/version 20131211 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_3 http://www.w3.org/ns/prov#value There was no difference in the magnitude of serum RBP4 elevation between the obese and obese-diabetic groups, suggesting that obesity and insulin resistance, but not hyperglycaemia, are associated with elevated serum RBP4 in humans. Rosiglitazone reverses RBP4 elevation The anti-diabetic agent rosiglitazone is a peroxisome proliferator activated receptor-gamma (PPARg) agonist that improves insulin sensitivity17. Treatment of adipose-Glut4-/- mice with rosiglitazone for three weeks completely reversed their insulin resistance and glucose intolerance18. http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_3 http://www.w3.org/ns/prov#wasQuotedFrom http://www.ncbi.nlm.nih.gov/pubmed/16034410 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_4 http://www.w3.org/2000/01/rdf-schema#label Selventa http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#assertion http://www.w3.org/ns/prov#hadPrimarySource http://www.ncbi.nlm.nih.gov/pubmed/16034410 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#_3 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg#pubinfo http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg http://purl.org/dc/terms/created 2014-07-03T14:32:48.021+02:00 http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg http://purl.org/pav/createdBy http://orcid.org/0000-0001-6818-334X http://www.tkuhn.ch/bel2nanopub/RADg62fTypZ-lEO6r37XWlco1fzPGkv6ikX94J399I3Tg http://purl.org/pav/createdBy http://orcid.org/0000-0002-1267-0234